The pro- gression from hypertension to congestive heart failure. JAMA. 1996;275:1557 1562. 19. Butler J, Kalogeropoulos AP, Georgiopoulou VV, Bibbins-Domingo K, Najjar SS, Sutton-Tyrrell KC, Harris TB, Kritchevsky SB, Lloyd- Jones DM, Newman AB, Psaty BM. Systolic blood pressure and incident heart failure in the elderly: the Cardiovascular Health Study and the Health, Ageing and Body Composition Study. Heart. 2011;97:1304 1311. doi: 10.1136/hrt.2011.225482. 20. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D Agostino RB, Levy D. Residual lifetime risk for developing hyper- tension in middle-aged women and men: the Framingham Heart Study. JAMA. 2002;287:1003 1010. 21. Effects of treatment on morbidity in hypertension, II: results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA. 1970;213:1143 1152. 22. Kostis JB, Davis BR, Cutler J, Grimm RH Jr, Berge KG, Cohen JD, Lacy CR, Perry HM Jr, Blaufox MD, Wassertheil-Smoller S, Black HR, Schron E, Berkson DM, Curb JD, Smith WM, McDonald R, Ap- plegate WB. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension: SHEP Cooperative Research Group. JAMA. 1997;278:212 216. 23. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenh ger WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O Brien ET, Rosenfeld J, Rodicio JL, Tu- omilehto J, Zanchetti A. Randomised double-blind comparison of placebo and active treatment for older patients with isolated sys- tolic hypertension: the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997;350:757 764. 24. Dahl f B, Lindholm LH, Hansson L, Scherst n B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Management of Comorbidities in Chronic Heart Failure CLINICAL STATEMENTS AND GUIDELINES Hypertension (STOP-Hypertension). Lancet. 1991;338:1281 1285. 25. Moser M, Hebert PR. 